NYSE - Nasdaq Real Time Price
USD
Eli Lilly and Company (LLY)
1,281.91
+2.77
(+0.22%)
At close: October 27 at 4:00:02 PM EDT
1,272.80
-8.72
(-0.68%)
Pre-Market: 9:20:57 AM EDT
Trade LLY on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreAnalyst Insights
Top Analyst
Cantor Fitzgerald
71/100
Analyst Price Targets
Analyst Recommendations
-
Strong Buy
-
Buy
-
Hold
-
Underperform
-
Sell
Latest Rating
Date
10/21/2026
Analyst
Leerink Partners
Rating Action
Maintains
Rating
Outperform
Price Action
Raises
Price Target
1309 -> 1316
Top Analysts
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more| Analyst
|
Overall Score
|
Direction Score
|
Price Score
|
Latest Rating
|
Price Target
|
Date
|
|---|---|---|---|---|---|---|
|
Cantor Fitzgerald
|
71 | 71 | 100 | Overweight
|
1440 | 2026-10-09 |
|
Guggenheim
|
70 | 73 | 82 | Buy
|
1284 | 2026-09-19 |
|
Truist Securities
|
67 | 68 | 100 | Buy
|
1376 | 2026-08-08 |
|
JP Morgan
|
67 | 67 | 97 | Overweight
|
1500 | 2026-09-28 |
|
HSBC
|
66 | 48 | 98 | Reduce
|
940 | 2026-09-11 |
|
Morgan Stanley
|
66 | 69 | 84 | Overweight
|
1430 | 2026-10-07 |
|
Wells Fargo
|
65 | 60 | 99 | Overweight
|
1330 | 2026-08-06 |
|
Barclays
|
58 | 56 | 100 | Overweight
|
1400 | 2026-05-05 |
|
Citigroup
|
58 | 60 | 76 | Buy
|
1600 | 2026-07-15 |
|
UBS
|
54 | 52 | 89 | Buy
|
1425 | 2026-07-13 |
Rows per page
1-10 of 15
Upgrades & Downgrades
| Maintains | Leerink Partners: Outperform to Outperform | 10/21/2026 |
| Reiterates | RBC Capital: Outperform to Outperform | 10/12/2026 |
| Maintains | Cantor Fitzgerald: Overweight to Overweight | 10/8/2026 |
| Maintains | Morgan Stanley: Overweight to Overweight | 10/7/2026 |
| Maintains | JP Morgan: Overweight to Overweight | 9/28/2026 |
| Reiterates | TD Cowen: Buy to Buy | 9/22/2026 |
